TCNNF Congressional Stock Trades
TRULIEVE CANNABIS CORP (TCNNF)
Last disclosed trade May 28
Every disclosed trade in TCNNF by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Greg Stanton · Sold $TCNNF · May 6 · $15K–$50K
Coldpine’s read
The spouse's Trulieve shares originated from her prior employment compensation, making periodic divestiture a routine portfolio management action rather than a directional view. The one-day disclosure lag is unusually fast for a House filing, indicating recent and timely reporting. No cluster activity from other members suggests this is an idiosyncratic, employment-linked sale rather than a sector signal.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $TCNNF
Get notified when any member of Congress trades $TCNNF. Free, no card, no spam.
The record on $TCNNF
Coldpine has parsed 2 disclosed trades in $TCNNF by 1 member of Congress, drawn from 2 periodic transaction reports dated May 6, 2026 through May 28, 2026. All of them came from House members, all filed by Democrats.
Of the 2 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 15 days. The longest was 29 days: a $TCNNF sale by Greg Stanton dated May 28, 2026, disclosed Jun 26, 2026. How late filing is measured across all of Congress is in the late-filers study.
2 of the 2 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Members who trade TCNNF
Recent disclosed trades in TCNNF
| Date | Member | Type | Amount |
|---|---|---|---|
| May 28 | Greg Stanton(AZ) | sell | $100K–$250K |
| May 6 | Greg Stanton(AZ) | sell | $15K–$50K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →